Manufacturing and Production

Showing 15 posts of 5860 posts found.

Abbott image

Abbott plans €85m investment in Irish facility

February 13, 2012 Manufacturing and Production Abbott. IDA, Ireland, Xinlay

Abbott Laboratories has said it will invest around €85 million in its manufacturing facility in Sligo, Ireland, more than doubling …

Excipient certification scheme launches

February 13, 2012 Manufacturing and Production EXCiPACT, GDP, GMP, manufacturing

A consortium of industry associations has launched a certification scheme for pharmaceutical excipients to make it easier for drugmakers to …

Pharma manufacturing news in brief

February 13, 2012 Manufacturing and Production Bosch, Lilly/Bend Research, Neuland, OctoPlus Ferring and CHEMO Particle Sciences

Neuland posts revenue gains, Bosch buys Eisi machinery, plus deals for Lilly/Bend Research, OctoPlus/Ferring and CHEMO/Particle Sciences.

SHL takes part in PharmTech.com’s “Pointed Debate: Expert Views on Injectables”

February 13, 2012 Manufacturing and Production auto injector, auto-injector, pen injector, shl group

SHL recently had the opportunity to participate along with various other experts in the industry in a questionnaire held by …

European Medicines Agency and European Food Safety Authority commit to a stronger collaboration

February 9, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The European Medicines Agency (EMA) and the European Food Safety Authority (EFSA) have agreed to work closer together on areas …

Hospira appoints Richard Davies as chief commercial officer

February 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hospira, Richard Davies

Hospira has announced Richard Davies as its senior vice president and chief commercial officer. In this role, he will be responsible for …
Breast cancer image

Breast cancer treatment – the next advances

February 7, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, CDF, Lorena Tonarelli, T-DM1, breast cancer, pertuzumab

When a close member of my family was diagnosed with breast cancer, the doctors didn’t give us much hope. They …

Dr Stephen Rosevear joins Cogent as director of Research & Policy

February 7, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cogent, Stephen Rosevear

Prior to joining Cogent, Stephen was HMRC’s chief analyst on the corporate real estate market, undertaking tax modeling and policy development for …

Working Life: Carlos Gallardo, general manager, Almirall

February 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Carlos Gallardo

BiographyCarlos Gallardo is general manager of the Almirall UK and Ireland affiliate from its creation in 2008. He has an …
AstraZeneca picture

AstraZeneca to cut 7,300 jobs as growth stalls

February 2, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, David Brennan, R&D

AstraZeneca will make 7,300 cuts to its sales and R&D staff by 2014, but the company has not yet said …
Pfizer picture

Pfizer recalls oral contraceptive for packaging errors

February 2, 2012 Manufacturing and Production Akrimax, Bedford, Cephalon, Lo/Ovral-28, Pfizer, Teva

Pfizer has been forced to recall a large volume of oral contraceptive packs distributed in the US market because a …

Catalent expands controlled release drug development and supply capabilities at its Schorndorf, Germany Facility

January 31, 2012 Manufacturing and Production

Somerset, NJ –January 25, 2012 — Catalent Pharma Solutions continues to expand its drug development and delivery capabilities to help …

Catalent acquires current minority interest in R.P. Scherer, Eberbach, Germany

January 31, 2012 Manufacturing and Production

SOMERSET, NJ, January 30, 2012 – Catalent Pharma Solutions, a leading global drug delivery technology company, today announced the signing …
Ranbaxy picture

Ranbaxy taken to task by FDA over manufacturing woes

January 31, 2012 Manufacturing and Production FDA, Ranbaxy, manufacturing, woes

Indian pharma company Ranbaxy will be banned from manufacturing drugs at certain plants for the US market until it corrects …

GMP issues affect Mircera, Xenical production at Roche plant

January 31, 2012 Manufacturing and Production GMP, Mircera, Roche, Tamiflu, Xenical

Supply of two Roche products has been disrupted after an active pharmaceutical ingredient (API) production facility in the US was …
The Gateway to Local Adoption Series

Latest content